Amgen's expenditure on research and development by category 2012-2017

The data displays the expenditure on research and development of biotech company Amgen in 2012 to 2017, sorted by category. Amgen is a U.S.-based multinational biopharmaceutical company, headquartered in Thousand Oaks, California. Amgen's R&D expenses amounted to approx. four billion USD in 2013. Of that amount, almost two billion USD were spent on later stage clinical programs.